Catalyst Wire Dossier Catalyst Wire Dossier

Neramexane Mesylate IR Tablet

neramexane mesylate · Merz Pharmaceuticals GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Neramexane Mesylate IR Tablet, covering 2009-12-07 to 2009-12-07. Get the full timeline:

Most recent: Clinical Trial Update: Investigate the Effect of Neramexane Mesylate IR Tablet on Driving Fitness and Capability to Operate Machines in Healthy Volunteers [Phase 1]

See pricing